As a specialized neuro‑diagnostic and neuromonitoring manufacturer, NCC Medical Group develops and produces complete Electromyography Device solutions for hospitals, clinics and research institutions worldwide. Established in 1997, NCC has grown from a small electrophysiology laboratory into a recognized provider of advanced IONM, EEG/PSG, EMG and medical consumables. Our Electromyography Device portfolio reflects this long‑term focus on neurophysiology: we offer systems that range from entry‑level EMG workstations for community hospitals to high‑channel, multi‑modal Electromyography Device platforms for academic centers and research labs.
NCC’s R&D and manufacturing operations are based in Shanghai, where dedicated engineering teams design the electronics, software and mechanics of each Electromyography Device. We operate modern production lines that include automated SMT assembly, in‑circuit testing and final system calibration. Every Electromyography Device undergoes a defined quality control process, including noise performance checks, signal linearity tests and long‑duration stability verification. This ensures that the Electromyography Device performs consistently even in demanding clinical environments. Our quality and compliance hub in Singapore coordinates international certifications and regulatory submissions, making sure that each Electromyography Device meets relevant standards in Asia, Europe, the Americas and other regions.
To support seamless global operations, NCC structures its business around three pillars. The R&D and manufacturing pillar focuses on core technology for the Electromyography Device, including amplifier design, artifact rejection algorithms and intelligent analysis modules. The global sales and export pillar manages distribution channels, OEM/ODM partnerships and regional marketing, helping local partners position the Electromyography Device effectively in their markets. The service and innovation pillar operates the NeuGuard Service Platform and the NCC Innovation Academy, providing training, remote technical support and continuous education related to the Electromyography Device and other neurophysiology products.
NCC’s solutions, including the Electromyography Device, are deployed in thousands of hospitals in China and more than 50 countries worldwide. Our customers range from top‑tier teaching hospitals that use the Electromyography Device for complex neuro‑muscular diagnostics and research, to regional centers that rely on the system for routine nerve conduction and EMG studies. We maintain 31 training and technical support centers across China, where clinicians and technicians receive hands‑on instruction in Electromyography Device operation, troubleshooting and interpretation. Internationally, we are actively expanding a distributor network and offer online training, webinars and on‑site startup support to ensure that each Electromyography Device is integrated smoothly into local workflows.
As a National “Little Giant” (SRDI) enterprise, NCC is recognized for Specialized, Refined, Differential and Innovational capabilities. This designation reflects our commitment to continuous innovation in areas such as intelligent EMG analysis, wireless acquisition modules and integrated multi‑modal platforms. Our mission is to safeguard life and health by providing tools that support safer surgeries, precise diagnostics and high‑quality patient care. The Electromyography Device is a key element of this mission, enabling clinicians to detect neuromuscular disorders earlier and manage them more effectively. For B2B partners, NCC offers flexible collaboration models around the Electromyography Device, including branding customization, interface localization and application‑specific software options, ensuring that each market can build a tailored neurophysiology solution on top of a robust, proven technology base.
Copyright © NCC Medical Co., Ltd. - Privacy policy